Torii Pharmaceutical Co Ltd
TSE:4551

Watchlist Manager
Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd
TSE:4551
Watchlist
Price: 4 555 JPY 4.59% Market Closed
Market Cap: 128B JPY
Have any thoughts about
Torii Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Torii Pharmaceutical Co Ltd stock under the Base Case scenario is 3 304.45 JPY. Compared to the current market price of 4 555 JPY, Torii Pharmaceutical Co Ltd is Overvalued by 27%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
3 304.45 JPY
Overvaluation 27%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Torii Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Torii Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Torii Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Torii Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Torii Pharmaceutical Co Ltd.

What unique competitive advantages
does Torii Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Torii Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Torii Pharmaceutical Co Ltd.

Provide P/S
for Torii Pharmaceutical Co Ltd.

Provide P/E
for Torii Pharmaceutical Co Ltd.

Provide P/OCF
for Torii Pharmaceutical Co Ltd.

Provide P/FCFE
for Torii Pharmaceutical Co Ltd.

Provide P/B
for Torii Pharmaceutical Co Ltd.

Provide EV/S
for Torii Pharmaceutical Co Ltd.

Provide EV/GP
for Torii Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Torii Pharmaceutical Co Ltd.

Provide EV/EBIT
for Torii Pharmaceutical Co Ltd.

Provide EV/OCF
for Torii Pharmaceutical Co Ltd.

Provide EV/FCFF
for Torii Pharmaceutical Co Ltd.

Provide EV/IC
for Torii Pharmaceutical Co Ltd.

Show me price targets
for Torii Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Torii Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Torii Pharmaceutical Co Ltd?

What are the Net Income projections
for Torii Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Torii Pharmaceutical Co Ltd?

What are the EPS projections
for Torii Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Torii Pharmaceutical Co Ltd?

What are the EBIT projections
for Torii Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Torii Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Torii Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Torii Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Torii Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Torii Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Torii Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Torii Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Torii Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Torii Pharmaceutical Co Ltd.

Provide ROE
for Torii Pharmaceutical Co Ltd.

Provide ROA
for Torii Pharmaceutical Co Ltd.

Provide ROIC
for Torii Pharmaceutical Co Ltd.

Provide ROCE
for Torii Pharmaceutical Co Ltd.

Provide Gross Margin
for Torii Pharmaceutical Co Ltd.

Provide Operating Margin
for Torii Pharmaceutical Co Ltd.

Provide Net Margin
for Torii Pharmaceutical Co Ltd.

Provide FCF Margin
for Torii Pharmaceutical Co Ltd.

Show all solvency ratios
for Torii Pharmaceutical Co Ltd.

Provide D/E Ratio
for Torii Pharmaceutical Co Ltd.

Provide D/A Ratio
for Torii Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Torii Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Torii Pharmaceutical Co Ltd.

Provide Quick Ratio
for Torii Pharmaceutical Co Ltd.

Provide Current Ratio
for Torii Pharmaceutical Co Ltd.

Provide Cash Ratio
for Torii Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Torii Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Torii Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Torii Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Torii Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Torii Pharmaceutical Co Ltd

Current Assets 87.2B
Cash & Short-Term Investments 42.2B
Receivables 27.9B
Other Current Assets 17.1B
Non-Current Assets 47.2B
Long-Term Investments 35.3B
PP&E 2.1B
Intangibles 375m
Other Non-Current Assets 9.5B
Current Liabilities 13.2B
Accounts Payable 8.6B
Accrued Liabilities 433m
Other Current Liabilities 4.2B
Non-Current Liabilities 694m
Other Non-Current Liabilities 694m
Efficiency

Earnings Waterfall
Torii Pharmaceutical Co Ltd

Revenue
57.2B JPY
Cost of Revenue
-31.8B JPY
Gross Profit
25.5B JPY
Operating Expenses
-18.8B JPY
Operating Income
6.7B JPY
Other Expenses
-1.4B JPY
Net Income
5.3B JPY

Free Cash Flow Analysis
Torii Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Torii Pharmaceutical Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
51/100
Profitability
Score

Torii Pharmaceutical Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Torii Pharmaceutical Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Torii Pharmaceutical Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Torii Pharmaceutical Co Ltd

Wall Street analysts forecast Torii Pharmaceutical Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Torii Pharmaceutical Co Ltd is 4 115.7 JPY with a low forecast of 3 838 JPY and a high forecast of 4 483.5 JPY.

Lowest
Price Target
3 838 JPY
16% Downside
Average
Price Target
4 115.7 JPY
10% Downside
Highest
Price Target
4 483.5 JPY
2% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Torii Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Torii Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd

Country

Japan

Industry

Pharmaceuticals

Market Cap

128B JPY

Dividend Yield

2.85%

Description

Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

Contact

TOKYO-TO
Chuo-Ku
Torii Nihombashi Bldg., 3-4-1, Nihombashi Hon-cho
+81332316811.0
www.torii.co.jp

IPO

2013-10-01

Employees

560

Officers

President, CEO & Representative Director
Mr. Goichi Matsuda
General Manager of Finance & Accounting Department
Yukihiro Takashima
Managing Executive Officer, Leader of Value Creation Group & GM of Business Development Department
Mr. Atsuyuki Kakee
Managing Executive Officer & Pharmaceutical Sales Group Leader
Mr. Katsunobu Fujiwara
Executive Deputy President & Representative Director
Mr. Nobumasa Kondo
Executive Officer, Head of Pharmacovigilance & Quality Assu Grp and Quality Assurance Grp Leader
Noriaki Nishino
Show More
Executive Officer
Shinichiro Arikawa
Show Less

See Also

Discover More
What is the Intrinsic Value of one Torii Pharmaceutical Co Ltd stock?

The intrinsic value of one Torii Pharmaceutical Co Ltd stock under the Base Case scenario is 3 304.45 JPY.

Is Torii Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 4 555 JPY, Torii Pharmaceutical Co Ltd is Overvalued by 27%.

Back to Top